Skip to main content
logo
Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0110
0.00 (0.00%)
Sep 18, 2026, 1:38 PM AEST

Cynata Therapeutics Revenue

In the fiscal year ending June 30, 2026, Cynata Therapeutics had annual revenue of 1.71M AUD, down -9.20%.

Revenue
1.71M
Revenue Growth
-9.20%
P/S Ratio
1.56
Revenue / Employee
855.81K
Employees
2
Market Cap
2.68M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20261.71M-173.52K-9.20%
Jun 30, 20251.89M-430.50K-18.59%
Jun 30, 20242.32M661.33K39.98%
Jun 30, 20231.65M-6.12M-78.71%
Jun 30, 20227.77M6.22M402.60%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Acrux6.58M
Tissue Repair2.99M
Vectus Biosystems2.77M
Bio-Gene Technology1.08M
Nexalis Therapeutics1.07M
Biotron525.87K
ReNerve510.36K
AdAlta404.25K
Revenue Rankings

Cynata Therapeutics News

More News